The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
No difference in meeting hemoglobin and albumin targets for dialyzed children with urologic disorders.
Division of Pediatric Nephrology, Johns Hopkins University, 200 N. Wolfe St., Baltimore, MD 21287, USA. email@example.com
Pediatric nephrology (Berlin, Germany) 2011;26(7):1129-36.
Urologic disorders are the most common cause of chronic kidney disease in children. To determine whether children with urologic etiology of end-stage renal disease (ESRD) fare better than children with ESRD from other causes while on dialysis, we conducted a cross-sectional study of children <18 years receiving peritoneal and hemodialysis in the United States using data from the Centers for Medicare & Medicaid Services 2005 ESRD CPM Project. We compared baseline demographics and the study groups. In multivariate logistic regression analysis of 1,286 subjects, we assessed whether children with urologic disorders had a higher odds of meeting adult KDOQI targets for hemoglobin levels ≥11 g/dl and albumin ≥3.5 BCG/3.2 BCP g/dl. We conducted a subset analysis of 1,136 patients to examine the impact of erythropoietin on hemoglobin targets. Our results did not reveal differences in achievement of adult hemoglobin targets (adjusted OR: 1.27; p value 0.09; CI: 0.97-1.66) or in the subset analysis with erythropoietin (adjusted OR: 1.32; p value 0.06; CI: 0.98-1.78) or albumin targets (adjusted OR: 1.22; p value 0.21; CI: 0.90-1.65) in adjusted analyses. Due to our study's limitations, it is difficult to determine whether this may result from treatment prior to dialysis initiation or treatment effect of dialysis rather than underlying diagnosis.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
M V Rocco; M R Bedinger; R Milam; J W Greer; W M McClellan; D L FrankenfieldAmerican journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4):813-23.
Diane L Frankenfield; Curtis A JohnsonAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002;59(5):429-35.
G R Bailie; D L Frankenfield; B F Prowant; W McClellan; M V RoccoAmerican journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(6):1187-9.
Appears in this Publication
Author of this Publication